Skip to main content
SpringerLink
Log in

Current Role of Herbal Preparations

  • Chapter
Antidepressants: Past, Present and Future

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 157))

  • 518 Accesses

Abstract

For many herbal remedies, precise information concerning composition, dose standardisation, clinical activity, interactions with other drugs and side effects is lacking. One of the best-researched herbal agents is St John's wort (hypericum). It has been shown to be an effective and safe antidepressant in more than 50 double-blind trials that involved comparisons with both placebo and standard antidepressants including selective serotonin reuptake inhibitors (SSRIs). Its mode of action, which involves reuptake inhibition of serotonin, noradrenaline and dopamine, is comparable to those of chemical antidepressants. Like the chemical antidepressants, it suffers from a “lag-period” of 3–4 weeks before it becomes fully effective and must be taken for at least 6 months to effect a lasting remission. It has been used in seasonal affective disorder (SAD) with good effect. Rarely, photosensitivity may occur, but only in cases of pathological sun allergy. Like chemical antidepressants, hypericum interacts in the metabolism of a number of other drugs, notably anticoagulants, theophylline preparations, oral contraceptives, antimigraine drugs, and HIV drugs. This may result in reduced effectiveness of both drugs and such combinations are therefore best avoided. A number of clinical trials have shown kava kava to be an effective anxiolytic and sleep-inducer, particularly in patients under stress. However, following reports of liver toxicity, it has been withdrawn from sale pending further investigation of these reports. On the other hand, valerian would appear to be a safe hypnotic for long-term use, although not for an immediate effect. Valerian increases deep (delta) sleep strikingly and beneficially and, by so doing, may augment the immune system. Ginkgo biloba enhances memory and the peripheral circulation. In double-blind trials, its efficacy has been demonstrated even in Alzheimer's disease, and it does not appear to have any appreciable side effects. Herbal remedies have much to offer in the treatment of psychiatric disorders and merit further scientific investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 509.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 649.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 649.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edition, revised. American Psychiatric Association, Washington, DC

    Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edition. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Baldwin D, Thomas SC, Birtwhistle J (1997) Effects of antidepressant drugs on sexual function. Int J Psych Clin Prac 1:47–58

    Article  CAS  Google Scholar 

  • Bennett DA Jr, Phun L, Polk JF, Voglino SA, Zlotnik V, Raffa RB (1998) Neuropharmacology of St John's Wort (Hypericum). Ann Pharmacother 32:1201–1208

    Article  PubMed  Google Scholar 

  • Bhate H, Gerster G, Graczca E (1989) Orale Pramedikation mit zubereitungan aus piper methysticum bei operativen eingriffen in epiduralanasthesie. Erfahrungsheilkunde 6:339–345

    Google Scholar 

  • Bove GM (1998) Acute neuropathy after exposure to sun in a patient treated with John's Wort. Lancet 352:1121–1122

    Article  PubMed  CAS  Google Scholar 

  • Brenner R, Azbel V, Madhausoodanan S, Pawlowska M (2000) Comparisons of an extract of hypericum (Li 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study. Clin Ther 22:411–419

    Article  PubMed  CAS  Google Scholar 

  • Brockmoller J, Reum T, Bauer S, Kerb R, Hubner WD, Roots I (1997) Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30(Suppl 2):94–101

    Article  PubMed  CAS  Google Scholar 

  • Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A (1997) Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 30(Suppl 2):117–124

    Article  PubMed  CAS  Google Scholar 

  • Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE (1998) Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci 63:499–510

    Article  PubMed  CAS  Google Scholar 

  • Coffey T (1993) The history and folklore of North American wild flowers. Houghton Miflin, Boston, pp 64–66

    Google Scholar 

  • Cohen AJ, Bartlik (1998) Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 24:139–145

    Article  PubMed  CAS  Google Scholar 

  • Connor KM, Watkins LL, Davidson JRT (2000) A study of an herbal anxiolytic. Presented at the 39th annual Meeting of the American College of Neuropsychopharmacology, 2000

    Google Scholar 

  • Cott JM (1995) Natural product formulations available in Europe for psychotropic medication. Psychopharmacol Bull 31:745–751

    PubMed  CAS  Google Scholar 

  • Cott JM (1997) In vitro receptor binding and enzyme inhibition by hypericum perforatum extract. Pharmacopsychiatry 30(Suppl 2):108–112

    Article  PubMed  CAS  Google Scholar 

  • DeFuria MD (1996) Taxol: Clinical development and commercializaton. Phytomedicine 3 (Suppl.1): 4

    Google Scholar 

  • Donath F, Quispe Bravo S, Diefenbach K, Fietz I, Roots I (1996/97) Polysomnographic and subjective findings in insomniacs under treatment with placebo and valerian extract (LI 156). Phytomedicine 3(Suppl 1):75

    Google Scholar 

  • Donath F, Quispe Bravo K, Diefenbach I, Maurer A, Fietze I, Roots I (2000) Critical evaluation of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33:47–53

    Article  PubMed  CAS  Google Scholar 

  • Drew AK, Myers SP (1997) Safety issues in herbal medicine. Med J Aust 166:538–541

    PubMed  CAS  Google Scholar 

  • Dunbar GC, Cohn IF, Feighner JP (1991) A comparison of paroxetine, imipramine and placebo in depressed outpatients. Human Psychopharmacology 11:283–291

    Google Scholar 

  • Ereshefsky L (2000) Advance in psychotropic CYP interactions. New Clinical Drug Evaluation Unit (NCDEU) annual meeting Boca Raton, National Institute of Mental Health USA

    Google Scholar 

  • Escher M, Desmeules J (2001) Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 322:139

    Article  PubMed  CAS  Google Scholar 

  • Farnsworth NR, Wagner H (1996/97) 2nd International congress on phytomedicine. Phytomedicine 3(Suppl1):1–304

    Google Scholar 

  • Grigson G (1958) The Englishmans flora. Hart-Davis McGibbbon, London, pp 83–89

    Google Scholar 

  • Grunze H, Walden J (1999) Kawain limits excitation in CA 1 pyramidal neurons of rats by modulating ionic currents and attenuating excitatory synaptic transmission. Hum Psychopharmacol Clin Exp 14:63–66

    Article  Google Scholar 

  • Guy W. ECDEU Assessment Manual for Psychopharmacology-3/4Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp. 218-222

    Google Scholar 

  • Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55

    Article  PubMed  CAS  Google Scholar 

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  PubMed  CAS  Google Scholar 

  • Hansel R, Haas H (1984) Therapie mit phytopharmaka. Springer Verlag, Heidelberg & New York

    Google Scholar 

  • Hansel R, Keller K, Rimpler H, Schneider D (eds) (1994) Hagers handbuch der pharmazeutischen praxis 6th ed, Drogen E-O. Springer-Verlag, Berlin Heidelberg New York, pp 201–221

    Google Scholar 

  • Hansgen KD, Vesper J, Ploch M (1994) Multi-center double-blind study examining the antidepressant effectiveness of hypericum extract LI 160. J Geriatr Psychiatry Neurol 7(Suppl 1):15–18

    Article  Google Scholar 

  • Harrer G, Hubner WD, Podzuweit H (1994) Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multi-center double-blind study, J Geriatr Psychiatry Neurol 7(Suppl 1):24–28

    Article  Google Scholar 

  • Hofmann R, Winter U (1993) Therapeutische moglichkeiten mit einem hochdosierten standardisierten kava-kava-paparat (antares 120) bei angsterkrangungen. V. Phytotherapiekongress, Bonn, Nov 3-5

    Google Scholar 

  • Kinsler E, Kromer J, Lehmann (1991) Wirksamkeit eines kava-spezial-extraktes bei patienten mit angst-, spannungs-, und erregungszustanden nicht-psychotischer genese. Arzneim Forsch/Drug Res 41:584–588

    Google Scholar 

  • Laakmann G, Schule C, Baghai T, Kieser M (1998) St John's Wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31:54–59

    Article  PubMed  CAS  Google Scholar 

  • Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 278:1327–1332

    Article  PubMed  Google Scholar 

  • Leathwood PD, Chaufford F (1983) Quantifying the effects of mild sedatives. J Psychiatr Res 17:115–122

    Article  CAS  Google Scholar 

  • Lehmann E, Kinsler E, Friedemann J (1996) Efficacy of a special kava extract (piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin: A double-blind placebo-controlled study of four weeks treatment. Phytomedicine 3:113–119

    Article  Google Scholar 

  • Leuschner J (1996/7) Preclinical toxicological profile of hypericum extract LI 160 (abstract) Int J Phytother Phytopharmacol 3(Suppl 1):34–38

    Google Scholar 

  • Lindahl O, Lindwall L (1989) Double blind study of a valerian preparation. Pharmacol Biochem Behav 32:1065–1066

    Article  PubMed  CAS  Google Scholar 

  • Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D (1996) St John's wort for depression—An overview and meta-analysis of randomised clinical trials. BMJ 313:253–258

    Article  PubMed  CAS  Google Scholar 

  • Lohse MJ, Muller-Oerlinghausen B (1994) In: Schwabe U, Paffrath D (eds) Arznieverordnungsreport, Stuttgart: 354–370

    Google Scholar 

  • Mendels J, Johnston R, Mattes J, Riesenberg R (1993) Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacol Bulletin 29:169–174

    CAS  Google Scholar 

  • Mohs RC. Rosen WG, Davis KL (1983) The Alzheimer's Disease Assessment Scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 19:448–450

    PubMed  CAS  Google Scholar 

  • Moller HJ (1996) Differences observed between Europe and USA with comparators, ACNP 35th Annual meeting, Puerto Rico

    Google Scholar 

  • Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389

    Article  PubMed  CAS  Google Scholar 

  • Monthly marketing data institute for medical statistics (1997) IMS, Frankfurt: December

    Google Scholar 

  • Muller WE, Rolli M, Schafer C, Hafner U (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry 30(Suppl 2):102–107

    Article  PubMed  CAS  Google Scholar 

  • Muller WE, Singer A, Wonnermann M (1998) Hyperforin represents the major re-uptake inhibiting constituent of St John's Wort, Poster American College of Psychopharmacology annual meeting, Puerto Rico.

    Google Scholar 

  • Nahrstedt A, Butterweck V (1997) Biologically active and other constituents of the herb of Hypericum perforatum. Pharmacopsychiatry 30(Suppl 2):129–134

    Article  PubMed  CAS  Google Scholar 

  • Oyama Y, Fuchs PA, Katayama N, Noda K (1994) Myricetin and quercetin, the flavonoid constituents of ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca-loaded brain neurons. Brain Res 635:125–129

    Article  PubMed  CAS  Google Scholar 

  • O'Breasail AM, Arguarch S (1998) Hypomania and St John.s Wort Can J Psychiatry 43:746–747

    Google Scholar 

  • Ozturk Y, Aydin S, Ozturk N, Bayer K. (1996/97) Effects of certain hypericum species on the central nervous system of mice (abstract), Int J Phytother Phytopharmacol 3(Suppl2):102

    Google Scholar 

  • Ozturk Y (1997) Testing of antidepressant effects of hypericum species on animal models Pharmacopsychiatry 30(Suppl 2):125–128

    Article  PubMed  Google Scholar 

  • Philipp M. Kohnen R, Hiller IO (1999) Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicenter study of treatment for eight weeks. BMJ 319:1534–9

    Article  PubMed  CAS  Google Scholar 

  • Porcher FP (1863) Resources of the fields and forests: Medical, economical and agricultural: prepared and published by order of the surgeon-general. Richmond VA. Reprint (1970), Arno Press, New York

    Google Scholar 

  • Rosenberg C, Damsbo N, Fuglum E, Jacobsen LV, Horsgard S (1994) Citalopram and imipramine in the treatment of depressive patients in general practice: A Nordic multicentre clinical study. Int Clin Psychopharmacol 9(Suppl 1):41–48

    Article  PubMed  Google Scholar 

  • Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA (1984) Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41:72–80

    Article  PubMed  CAS  Google Scholar 

  • Schneck C (1998) St John's Wort and hypomania. J Clin Psychiatry 59:12

    Article  Google Scholar 

  • Schneider B (1992) Ginkgo-biloba-extrakt bei peripheren arteriellen verschlusskrankheiten. Arzneim Forsch/Drug Res 42:428–436

    CAS  Google Scholar 

  • Schrader E (2000) Equivalence of St. Johns wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression Int Clin Psychopharmacology 15:61–8.

    Article  CAS  Google Scholar 

  • Schrader E, Meier B, Brattstrom A (1998) Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Human Psychopharmacology 13:163–169

    Article  Google Scholar 

  • Schulz V, Hansel R, Tyler VE (1998) Rational phytotherapy. Springer-Verlag, Berlin, Heidelberg

    Book  Google Scholar 

  • Schulz V, Jobert M (1994) Effects of hypericum extract on the sleep EEG in older volunteers. J Geriatr Psychiatry Neurol 7(Suppl 1):S49–S43

    Google Scholar 

  • Schwartz GE, Loew DM (1983) Assessment of psychopathology by significant others. In: Crook T, Ferrio S, Bartus R (eds) Assessment in geriatric psychopharmacology. Mark Powley Associates, New Canaan CT, pp 111–117

    Google Scholar 

  • Segraves RT (1998) Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59(Suppl 4):48–54

    PubMed  CAS  Google Scholar 

  • Singh YN (1992) Kava: An overview. J Ethnopharmacol 37:13–45

    Article  PubMed  CAS  Google Scholar 

  • Sommer H, Harrer G (1994) Placebo-controlled double-blind study examining the anti-depressant effectiveness of a hypericum preparation in 105 mildly depressed patients J Geriatr Psychiatry Neurol 7(Suppl):9–11

    Article  Google Scholar 

  • Smith DA (1997) Side-effects of psychotropic drugs. In: Wheatley D, Smith DA (eds) Psychopharmacology of cognitive and psychiatric disorders in the elderly. Chapman & Hall, London, pp 36–54

    Google Scholar 

  • Stein JD, Hollander E (1994) Sexual dysfunction associated with the drug treatment of psychiatric disorders. CNS Drugs 2:78–86

    Article  Google Scholar 

  • Stevinson C, Ernst E (1999) Safety of hypericum in patients with depression. CNS Drugs 2:125–132

    Article  Google Scholar 

  • Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B (1989) Light therapy for seasonal affective disorder: A review of efficacy. Neuropsychopharmacolgy 2:1–22

    Article  CAS  Google Scholar 

  • Teufel-Mayer R, Gleitz J (1997) Effects of long-term administration of hypericum extracts on the affinity and density of the central serotinergic 5-HT1A and HT2A receptors. Pharmacopsychiatry 30(Suppl 2):113–116

    Article  PubMed  CAS  Google Scholar 

  • Volz HP (1995) Die anziolytische wirksamkeit von kava-spezialextrakt WS 1490 unter langzeithetherapie-eine randomisierte doppelblindstudie. Z Phytother Abstract-bande: 9

    Google Scholar 

  • Volz HP, Hansel R (1994) Kava-kava und kavain in der psychopharmakotherapie. Psychopharmakotherapie 1:33–39

    Google Scholar 

  • Volz HP, Kieser M (1997) Kava-kava extract WS1490 versus placebo in anxiety disorders-a randomised placebo-controlled 25-week outpatient trial. Pharmacopsychiatrt 30:1–5

    Article  CAS  Google Scholar 

  • Vorbach EU, Arnoldt KH, Hubner WD (1997) Efficacy and tolerability of St John's Wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 30(suppl):81–85

    Article  PubMed  CAS  Google Scholar 

  • Vorbach EU, Hubner WD, Arnoldt KH (1994) Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: Randomised double-blind study in 135 outpatients. J Geriatr Psychiatry Neurol 7(Suppl):19–23

    Article  Google Scholar 

  • Walden J, von Wegerer J, Winter U, Berger M, Grunze H (1997) Effects of kawain and dihydromethisticin on field potential changes in the hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 21:697–706

    Article  PubMed  CAS  Google Scholar 

  • Warnecke G, Pfaender H, Gerster G, Gracza E (1995) Wirksamkeit von kava-spezialextrakt beim klimakterischen syndrom. Z Phytother 11:81–86

    Google Scholar 

  • Wheatley D (1992) Prescribing short-acting hypnosedatives. Drug Safety 7:106–115

    Article  PubMed  CAS  Google Scholar 

  • Wheatley D (1993a) The Wheatley Stress Profile. Stress Medicine 9:5–9

    Article  Google Scholar 

  • Wheatley D (1993b) Sleep in anxiety and depression associated with stress. Stress Medicine 9:127–129

    Article  Google Scholar 

  • Wheatley D (1997a) LI 160, an extract of St John's Wort, versus amitriptyline in mildly to moderately depressed outpatients—A controlled 6-week clinical trial. Pharmacopsychiatry 30(Suppl):77–80

    Article  PubMed  CAS  Google Scholar 

  • Wheatley D (1997b) Stress, anxiety and depression. Stress Medicine 13:173–177

    Article  Google Scholar 

  • Wheatley D (1998a) Hypericum extract: Potential in the treatment of depression. CNS Drugs 6:431–440

    Article  Google Scholar 

  • Wheatley D (1998b) Sex, stress and sleep. Stress Medicine 14:245–248

    Article  Google Scholar 

  • Wheatley D (1998c) Mirtazapine, a new dual action antidepressant. Prescriber 9:97–99

    Google Scholar 

  • Wheatley D (1998d) Sexual dysfunction and sleep disturbance. Psychiatry in Practice 17:10–12

    Google Scholar 

  • Wheatley D (1999a) Hypericum in seasonal affective disorder (SAD). Curr Med Res Opin 15:33–37

    Article  PubMed  CAS  Google Scholar 

  • Wheatley D (1999b) Ginkgo biloba in the treatment of sexual dysfunction due to antidepressant drugs. Human Psychopharmacology 14:511–513

    Article  Google Scholar 

  • Wheatley D (2001a). Kava-kava in the treatment of generalized anxiety disorder. Primary Care Psychiatry 7:97–100

    Article  Google Scholar 

  • Wheatley D (2001b) Stress-induced insomnia treated with kava and valerian singly and in combination. Human Psychopharmacology 16:353–356

    Article  PubMed  Google Scholar 

  • Winterhoff H, Butterweck V, Nahrsted A, Schulz V, Wall A (1995) Pharmacologische untersuchungen zur antidepressiven virkung von hypericum perforatum L. In: Loew D, Rietbrook N (eds) Phytopharmaca im forschund Klinischer anwendung. Steinkopf, Darmstadt, pp 39–56

    Chapter  Google Scholar 

  • Woelk H, Burkhard G, Grunwald J (1994) Hypericum extract LI 160: Drug monitoring with 3250 patients. J Geriatr Psychiatry Neurol 7(Suppl 1):34–38

    Article  Google Scholar 

  • Woelk H, Kapoula O, Lehrl S (1993) Berhandlung von angst-patienten. Z Allg Med 69:271–277

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 10 Harley Street, London, W1G 2PF, UK

    D. Wheatley

  2. 15 Elizabeth Court, Lower Kings Rd., Kingston-on-Thames, Surrey, KT2 5HP, UK

    D. Wheatley

Authors
  1. D. Wheatley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine and Psychiatric Research Insitute, 1010 N. Kansas, Wichita, Kansas, 67214, USA

    Sheldon H. Preskorn

  2. Feighner Research Institute, 5230 Carrol Canyon Rd # 220, San Diego, CA, 92121, USA

    John P. Feighner (President and Director of Research) (President and Director of Research)

  3. W8057 Moonlite Road, Neillsville, WI, 54456, USA

    Christina Y. Stanga

  4. Ross Editorial, 228 Black Rock Mtn Ln, Independence, VA, 24348, USA

    Ruth Ross

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wheatley, D. (2004). Current Role of Herbal Preparations. In: Preskorn, S.H., Feighner, J.P., Stanga, C.Y., Ross, R. (eds) Antidepressants: Past, Present and Future. Handbook of Experimental Pharmacology, vol 157. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18500-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18500-7_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62135-2

  • Online ISBN: 978-3-642-18500-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation